Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by ...

As Ozempic reshapes the weight-loss landscape, doctors say there’s a crucial part of the story many users overlook until it’s too late.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs are ...

The time of day that cancer drugs are administered could make a big difference to a patient's outcomes, and would be a ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and ...

Like Ozempic and Wegovy, Mounjaro and Zepbound can help people control blood sugar levels and reduce or maintain weight. While these GLP-1 drugs are not recommended for short-term use, people stop ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...

Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it, you might ...

Mapping how Narcan reverses opioid overdose can provide a molecular blueprint for developing more effective drugs against ...